 | • レポートコード：GIR201112086 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ヒト組み換えインスリンの世界市場を調査対象にし、ヒト組み換えインスリンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（速効型ヒトインスリン、通常（短時間作用型）インスリン、NPH（中間作用型）インスリン、長時間作用型ヒトインスリン、プレミックスヒトインスリンインスリン）、用途別分析（病院、小売薬局、オンライン薬局、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Novo Nordisk、Biocon、Julphar Gulf Pharmaceutical Industries、Eli Lilly and Company、Zhuhai United Laboratories、Sanofi、Dongbao Enterprise Group、Gan & Lee Pharmaceuticals、Bioton、Wanbang Biopharmaceuticals、PeproTech ・メーカー別販売量、売上、市場シェア ・ヒト組み換えインスリンの地域別市場分析 ・ヒト組み換えインスリンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ヒト組み換えインスリンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ヒト組み換えインスリンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ヒト組み換えインスリンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ヒト組み換えインスリンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ヒト組み換えインスリンの種類別市場規模2015-2020：速効型ヒトインスリン、通常（短時間作用型）インスリン、NPH（中間作用型）インスリン、長時間作用型ヒトインスリン、プレミックスヒトインスリンインスリン ・ヒト組み換えインスリンの用途別市場規模2015-2020：病院、小売薬局、オンライン薬局、その他 ・ヒト組み換えインスリンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Human Recombinant Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Human Recombinant Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Recombinant Insulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Recombinant Insulin market has been segmented into
Rapid-Acting Human Insulin
Regular (Short Acting) Insulin
NPH (Intermediate Acting) Insulin
Long-Acting Human Insulin
Premixed Human Insulins Insulin
By Application, Human Recombinant Insulin has been segmented into:
Hospital
Retail Pharmacy
Online Pharmacies
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Recombinant Insulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Recombinant Insulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Recombinant Insulin market.
The report offers in-depth assessment of the growth and other aspects of the Human Recombinant Insulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Recombinant Insulin Market Share Analysis
Human Recombinant Insulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Recombinant Insulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Recombinant Insulin sales, revenue and market share for each player covered in this report.
The major players covered in Human Recombinant Insulin are:
Novo Nordisk
Biocon
Julphar Gulf Pharmaceutical Industries
Eli Lilly and Company
Zhuhai United Laboratories
Sanofi
Dongbao Enterprise Group
Gan & Lee Pharmaceuticals
Bioton
Wanbang Biopharmaceuticals
PeproTech
Among other players domestic and global, Human Recombinant Insulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Recombinant Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Recombinant Insulin, with price, sales, revenue and global market share of Human Recombinant Insulin in 2018 and 2019.
Chapter 3, the Human Recombinant Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Recombinant Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Recombinant Insulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Recombinant Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Human Recombinant Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Recombinant Insulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Rapid-Acting Human Insulin
1.2.3 Regular (Short Acting) Insulin
1.2.4 NPH (Intermediate Acting) Insulin
1.2.5 Long-Acting Human Insulin
1.2.6 Premixed Human Insulins Insulin
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Recombinant Insulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Overview of Global Human Recombinant Insulin Market
1.4.1 Global Human Recombinant Insulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biocon
2.2.1 Biocon Details
2.2.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biocon SWOT Analysis
2.2.4 Biocon Product and Services
2.2.5 Biocon Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Julphar Gulf Pharmaceutical Industries
2.3.1 Julphar Gulf Pharmaceutical Industries Details
2.3.2 Julphar Gulf Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Julphar Gulf Pharmaceutical Industries SWOT Analysis
2.3.4 Julphar Gulf Pharmaceutical Industries Product and Services
2.3.5 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zhuhai United Laboratories
2.5.1 Zhuhai United Laboratories Details
2.5.2 Zhuhai United Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zhuhai United Laboratories SWOT Analysis
2.5.4 Zhuhai United Laboratories Product and Services
2.5.5 Zhuhai United Laboratories Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dongbao Enterprise Group
2.7.1 Dongbao Enterprise Group Details
2.7.2 Dongbao Enterprise Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dongbao Enterprise Group SWOT Analysis
2.7.4 Dongbao Enterprise Group Product and Services
2.7.5 Dongbao Enterprise Group Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Gan & Lee Pharmaceuticals
2.8.1 Gan & Lee Pharmaceuticals Details
2.8.2 Gan & Lee Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Gan & Lee Pharmaceuticals SWOT Analysis
2.8.4 Gan & Lee Pharmaceuticals Product and Services
2.8.5 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bioton
2.9.1 Bioton Details
2.9.2 Bioton Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bioton SWOT Analysis
2.9.4 Bioton Product and Services
2.9.5 Bioton Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Wanbang Biopharmaceuticals
2.10.1 Wanbang Biopharmaceuticals Details
2.10.2 Wanbang Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Wanbang Biopharmaceuticals SWOT Analysis
2.10.4 Wanbang Biopharmaceuticals Product and Services
2.10.5 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 PeproTech
2.11.1 PeproTech Details
2.11.2 PeproTech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 PeproTech SWOT Analysis
2.11.4 PeproTech Product and Services
2.11.5 PeproTech Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Recombinant Insulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Recombinant Insulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Recombinant Insulin Manufacturer Market Share in 2019
3.3.2 Top 6 Human Recombinant Insulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Recombinant Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Recombinant Insulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Recombinant Insulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Recombinant Insulin Sales and Growth Rate (2015-2020)
4.3 Europe Human Recombinant Insulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Recombinant Insulin Sales and Growth Rate (2015-2020)
4.5 South America Human Recombinant Insulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Recombinant Insulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Recombinant Insulin Sales, Revenue and Market Share by Country
5.1.1 North America Human Recombinant Insulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Recombinant Insulin Revenue and Market Share by Country (2015-2020)
5.2 United States Human Recombinant Insulin Sales and Growth Rate (2015-2020)
5.3 Canada Human Recombinant Insulin Sales and Growth Rate (2015-2020)
5.4 Mexico Human Recombinant Insulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Recombinant Insulin Sales, Revenue and Market Share by Country
6.1.1 Europe Human Recombinant Insulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Recombinant Insulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Recombinant Insulin Sales and Growth Rate (2015-2020)
6.3 UK Human Recombinant Insulin Sales and Growth Rate (2015-2020)
6.4 France Human Recombinant Insulin Sales and Growth Rate (2015-2020)
6.5 Russia Human Recombinant Insulin Sales and Growth Rate (2015-2020)
6.6 Italy Human Recombinant Insulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Recombinant Insulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Recombinant Insulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Recombinant Insulin Revenue and Market Share by Regions (2015-2020)
7.2 China Human Recombinant Insulin Sales and Growth Rate (2015-2020)
7.3 Japan Human Recombinant Insulin Sales and Growth Rate (2015-2020)
7.4 Korea Human Recombinant Insulin Sales and Growth Rate (2015-2020)
7.5 India Human Recombinant Insulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Recombinant Insulin Sales and Growth Rate (2015-2020)
7.7 Australia Human Recombinant Insulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Recombinant Insulin Sales, Revenue and Market Share by Country
8.1.1 South America Human Recombinant Insulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Recombinant Insulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Recombinant Insulin Sales and Growth Rate (2015-2020)
8.3 Argentina Human Recombinant Insulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Recombinant Insulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Recombinant Insulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Recombinant Insulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Recombinant Insulin Sales and Growth Rate (2015-2020)
9.3 Turkey Human Recombinant Insulin Sales and Growth Rate (2015-2020)
9.4 Egypt Human Recombinant Insulin Sales and Growth Rate (2015-2020)
9.5 South Africa Human Recombinant Insulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Recombinant Insulin Sales and Market Share by Type (2015-2020)
10.2 Global Human Recombinant Insulin Revenue and Market Share by Type (2015-2020)
10.3 Global Human Recombinant Insulin Price by Type (2015-2020)
11 Global Human Recombinant Insulin Market Segment by Application
11.1 Global Human Recombinant Insulin Sales Market Share by Application (2015-2020)
11.2 Global Human Recombinant Insulin Revenue Market Share by Application (2015-2020)
11.3 Global Human Recombinant Insulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Recombinant Insulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Recombinant Insulin Market Forecast by Regions (2021-2025)
12.2.1 North America Human Recombinant Insulin Market Forecast (2021-2025)
12.2.2 Europe Human Recombinant Insulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Recombinant Insulin Market Forecast (2021-2025)
12.2.4 South America Human Recombinant Insulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Recombinant Insulin Market Forecast (2021-2025)
12.3 Human Recombinant Insulin Market Forecast by Type (2021-2025)
12.3.1 Global Human Recombinant Insulin Sales Forecast by Type (2021-2025)
12.3.2 Global Human Recombinant Insulin Market Share Forecast by Type (2021-2025)
12.4 Human Recombinant Insulin Market Forecast by Application (2021-2025)
12.4.1 Global Human Recombinant Insulin Sales Forecast by Application (2021-2025)
12.4.2 Global Human Recombinant Insulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Human Recombinant Insulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Recombinant Insulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Recombinant Insulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Human Recombinant Insulin Major Business
Table 9. Novo Nordisk Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 10. Novo Nordisk SWOT Analysis
Table 11. Novo Nordisk Human Recombinant Insulin Product and Services
Table 12. Novo Nordisk Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biocon Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Human Recombinant Insulin Major Business
Table 15. Biocon Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 16. Biocon SWOT Analysis
Table 17. Biocon Human Recombinant Insulin Product and Services
Table 18. Biocon Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Julphar Gulf Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 20. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Major Business
Table 21. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 22. Julphar Gulf Pharmaceutical Industries SWOT Analysis
Table 23. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product and Services
Table 24. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly and Company Human Recombinant Insulin Major Business
Table 27. Eli Lilly and Company Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 28. Eli Lilly and Company SWOT Analysis
Table 29. Eli Lilly and Company Human Recombinant Insulin Product and Services
Table 30. Eli Lilly and Company Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Zhuhai United Laboratories Human Recombinant Insulin Major Business
Table 33. Zhuhai United Laboratories Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 34. Zhuhai United Laboratories SWOT Analysis
Table 35. Zhuhai United Laboratories Human Recombinant Insulin Product and Services
Table 36. Zhuhai United Laboratories Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Human Recombinant Insulin Major Business
Table 39. Sanofi Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Human Recombinant Insulin Product and Services
Table 42. Sanofi Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Dongbao Enterprise Group Basic Information, Manufacturing Base and Competitors
Table 44. Dongbao Enterprise Group Human Recombinant Insulin Major Business
Table 45. Dongbao Enterprise Group Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 46. Dongbao Enterprise Group SWOT Analysis
Table 47. Dongbao Enterprise Group Human Recombinant Insulin Product and Services
Table 48. Dongbao Enterprise Group Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Gan & Lee Pharmaceuticals Human Recombinant Insulin Major Business
Table 51. Gan & Lee Pharmaceuticals Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 52. Gan & Lee Pharmaceuticals SWOT Analysis
Table 53. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product and Services
Table 54. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bioton Basic Information, Manufacturing Base and Competitors
Table 56. Bioton Human Recombinant Insulin Major Business
Table 57. Bioton Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 58. Bioton SWOT Analysis
Table 59. Bioton Human Recombinant Insulin Product and Services
Table 60. Bioton Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Wanbang Biopharmaceuticals Human Recombinant Insulin Major Business
Table 63. Wanbang Biopharmaceuticals Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 64. Wanbang Biopharmaceuticals SWOT Analysis
Table 65. Wanbang Biopharmaceuticals Human Recombinant Insulin Product and Services
Table 66. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. PeproTech Basic Information, Manufacturing Base and Competitors
Table 68. PeproTech Human Recombinant Insulin Major Business
Table 69. PeproTech Human Recombinant Insulin Total Revenue (USD Million) (2017-2018)
Table 70. PeproTech SWOT Analysis
Table 71. PeproTech Human Recombinant Insulin Product and Services
Table 72. PeproTech Human Recombinant Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Human Recombinant Insulin Sales by Manufacturer (2018-2019) (K Litre)
Table 74. Global Human Recombinant Insulin Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Human Recombinant Insulin Sales by Regions (2015-2020) (K Litre)
Table 76. Global Human Recombinant Insulin Sales Market Share by Regions (2015-2020)
Table 77. Global Human Recombinant Insulin Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Human Recombinant Insulin Sales by Countries (2015-2020) (K Litre)
Table 79. North America Human Recombinant Insulin Sales Market Share by Countries (2015-2020)
Table 80. North America Human Recombinant Insulin Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Human Recombinant Insulin Revenue Market Share by Countries (2015-2020)
Table 82. Europe Human Recombinant Insulin Sales by Countries (2015-2020) (K Litre)
Table 83. Europe Human Recombinant Insulin Sales Market Share by Countries (2015-2020)
Table 84. Europe Human Recombinant Insulin Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Human Recombinant Insulin Sales by Regions (2015-2020) (K Litre)
Table 86. Asia-Pacific Human Recombinant Insulin Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Human Recombinant Insulin Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Human Recombinant Insulin Sales by Countries (2015-2020) (K Litre)
Table 89. South America Human Recombinant Insulin Sales Market Share by Countries (2015-2020)
Table 90. South America Human Recombinant Insulin Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Human Recombinant Insulin Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Human Recombinant Insulin Sales by Countries (2015-2020) (K Litre)
Table 93. Middle East & Africa Human Recombinant Insulin Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Human Recombinant Insulin Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Human Recombinant Insulin Revenue Market Share by Countries (2015-2020)
Table 96. Global Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 97. Global Human Recombinant Insulin Sales Share by Type (2015-2020)
Table 98. Global Human Recombinant Insulin Revenue by Type (2015-2020) (USD Million)
Table 99. Global Human Recombinant Insulin Revenue Share by Type (2015-2020)
Table 100. Global Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 101. Global Human Recombinant Insulin Sales Share by Application (2015-2020)
Table 102. Global Human Recombinant Insulin Sales Forecast by Regions (2021-2025) (K Litre)
Table 103. Global Human Recombinant Insulin Market Share Forecast by Regions (2021-2025)
Table 104. Global Human Recombinant Insulin Sales Forecast by Type (2021-2025) (K Litre)
Table 105. Global Human Recombinant Insulin Market Share Forecast by Type (2021-2025)
Table 106. Global Human Recombinant Insulin Sales Forecast by Application (2021-2025)
Table 107. Global Human Recombinant Insulin Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Recombinant Insulin Picture
Figure 2. Global Sales Market Share of Human Recombinant Insulin by Type in 2019
Figure 3. Rapid-Acting Human Insulin Picture
Figure 4. Regular (Short Acting) Insulin Picture
Figure 5. NPH (Intermediate Acting) Insulin Picture
Figure 6. Long-Acting Human Insulin Picture
Figure 7. Premixed Human Insulins Insulin Picture
Figure 8. Human Recombinant Insulin Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Online Pharmacies Picture
Figure 12. Other Picture
Figure 13. Global Human Recombinant Insulin Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Human Recombinant Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Human Recombinant Insulin Sales Market Share by Manufacturer in 2019
Figure 34. Global Human Recombinant Insulin Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Human Recombinant Insulin Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Human Recombinant Insulin Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 39. Global Human Recombinant Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Human Recombinant Insulin Revenue Market Share by Regions (2015-2020)
Figure 41. Global Human Recombinant Insulin Revenue Market Share by Regions in 2018
Figure 42. North America Human Recombinant Insulin Sales and Growth Rate (2015-2020)
Figure 43. Europe Human Recombinant Insulin Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Human Recombinant Insulin Sales and Growth Rate (2015-2020)
Figure 45. South America Human Recombinant Insulin Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Human Recombinant Insulin Sales and Growth Rate (2015-2020)
Figure 47. North America Human Recombinant Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Human Recombinant Insulin Sales Market Share by Countries (2015-2020)
Figure 49. North America Human Recombinant Insulin Sales Market Share by Countries in 2018
Figure 50. North America Human Recombinant Insulin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Human Recombinant Insulin Revenue Market Share by Countries in 2018
Figure 52. United States Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 53. Canada Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 54. Mexico Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 55. Europe Human Recombinant Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Human Recombinant Insulin Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Human Recombinant Insulin Revenue Market Share by Countries in 2019
Figure 58. Germany Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 59. UK Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 60. France Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 61. Russia Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 62. Italy Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 63. Asia-Pacific Human Recombinant Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Human Recombinant Insulin Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Human Recombinant Insulin Revenue Market Share by Regions 2019
Figure 66. China Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 67. Japan Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 68. Korea Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 69. India Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 70. Southeast Asia Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 71. South America Human Recombinant Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Human Recombinant Insulin Sales Market Share by Countries in 2019
Figure 73. South America Human Recombinant Insulin Revenue Market Share by Countries in 2019
Figure 74. Brazil Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 75. Argentina Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 76. Middle East and Africa Human Recombinant Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Human Recombinant Insulin Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Human Recombinant Insulin Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Human Recombinant Insulin Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 81. Egypt Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 82. Turkey Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 83. South Africa Human Recombinant Insulin Sales and Growth Rate (2015-2020) (K Litre)
Figure 84. Global Human Recombinant Insulin Sales and Growth Rate (2021-2025) (K Litre)
Figure 85. Global Human Recombinant Insulin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Human Recombinant Insulin Market Forecast (2021-2025) (K Litre)
Figure 87. Europe Sales Human Recombinant Insulin Market Forecast (2021-2025) (K Litre)
Figure 88. Asia-Pacific Sales Human Recombinant Insulin Market Forecast (2021-2025) (K Litre)
Figure 89. South America Sales Human Recombinant Insulin Market Forecast (2021-2025) (K Litre)
Figure 90. Middle East & Africa Sales Human Recombinant Insulin Market Forecast (2021-2025) (K Litre)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
インスリンの世界市場 2020年 Market Overview The Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- インスリンAPIの世界市場 2020年 Market Overview The Insulin API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- インスリンペンの世界市場 2020年 Market Overview The Insulin Pen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- インスリン様成長因子Iの世界市場 2020年 Market Overview The global Insulin Like Growth Factor I market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insulin Like Gro…
- インスリンデテミルの世界市場 2020年 Market Overview The global Insulin Detemir market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insulin Detemir market report…